You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
恆康醫療(002219.SZ):出售恆康醫療投資(澳大利亞)股權完成交割
格隆匯 11-29 18:20

格隆匯11月29日丨恆康醫療(002219.SZ)公佈,公司分別於2019年11月5日、2019年11月21日召開第五屆董事會第十八次會議、2019年第七次臨時股東大會審議通過了《關於出售全資子公司股權的議案》,同意公司出售澳大利亞全資子公司恆康醫療投資(澳大利亞)有限責任公司(“標的公司”)100%的股權,標的公司持有PRP Diagnostic Imaging Holdings Limited(“PRP公司”)70.33%的股權。此次股權出售價款約為人民幣4841.7萬元,此次交易交割完成後公司享有標的公司的所有權利和義務(含債務擔保)隨之一併轉讓。

2019年11 月29日,交易各方共同簽署了此次股權轉讓交割相關的法律文件,此次交易的全部交割事項均已完成。根據《股權轉讓協議》的約定,此次交易交割完成後公司享有標的公司的所有權利和義務(含債務擔保)隨之一併轉讓,公司對標的公司債務的相關擔保以及標的公司收購PRP公司剩餘股權的擔保亦一併解除。買方PRP Group Pty Ltd根據《股權轉讓協議》的約定支付了全部股權轉讓對價款,標的公司的股權轉移至PRP Group Pty Ltd名下。此次交易交割完成後,公司不再持有標的公司的股權,標的公司將不再納入公司合併報表範圍。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account